Year |
Citation |
Score |
2016 |
Tomin K, Goldfarb RH, Albertsson P. In Vitro Assessment of Human Natural Killer Cell Migration and Invasion. Methods in Molecular Biology (Clifton, N.J.). 1441: 65-74. PMID 27177657 DOI: 10.1007/978-1-4939-3684-7_6 |
0.384 |
|
2011 |
Edsparr K, Basse PH, Goldfarb RH, Albertsson P. Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 4: 351-60. PMID 22161319 DOI: 10.1007/S12307-010-0057-0 |
0.37 |
|
2011 |
Rastelli L, Valentino ML, Minderman MC, Landin J, Malyankar UM, Lescoe MK, Kitson R, Brunson K, Souan L, Forenza S, Goldfarb RH, Rabbani SA. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo. International Journal of Oncology. 39: 401-8. PMID 21567086 DOI: 10.3892/Ijo.2011.1040 |
0.363 |
|
2010 |
Edsparr K, Speetjens FM, Mulder-Stapel A, Goldfarb RH, Basse PH, Lennernäs B, Kuppen PJ, Albertsson P. Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2-independent NK cell line YT. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 475-81. PMID 20463600 DOI: 10.1097/Cji.0B013E3181D372A0 |
0.435 |
|
2009 |
Edsparr K, Johansson BR, Goldfarb RH, Basse PH, Nannmark U, Speetjens FM, Kuppen PJ, Lennernäs B, Albertsson P. Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP expression. Immunology and Cell Biology. 87: 489-95. PMID 19434071 DOI: 10.1038/Icb.2009.35 |
0.45 |
|
2007 |
Albertsson P, Basse PH, Edsparr K, Kim MH, Goldfarb RH, Golfarb RH, Kitson RP, Lennernäs B, Nannmark U, Johansson BR. Differential locomotion of long- and short-term IL-2-activated murine natural killer cells in a model matrix environment. Scandinavian Journal of Immunology. 66: 402-9. PMID 17850584 DOI: 10.1111/j.1365-3083.2007.01956.x |
0.43 |
|
2006 |
Lu M, Dou QP, Kitson RP, Smith DM, Goldfarb RH. Differential effects of proteasome inhibitors on cell cycle and apoptotic pathways in human YT and Jurkat cells. Journal of Cellular Biochemistry. 97: 122-34. PMID 16173095 DOI: 10.1002/Jcb.20543 |
0.488 |
|
2004 |
Gellert GC, Goldfarb RH, Kitson RP. Physical association of uPAR with the alphaV integrin on the surface of human NK cells. Biochemical and Biophysical Research Communications. 315: 1025-32. PMID 14985115 DOI: 10.1016/J.Bbrc.2004.01.163 |
0.729 |
|
2004 |
Reshetnyak YK, Kitson RP, Lu M, Goldfarb RH. Conformational and enzymatic changes of 20S proteasome of rat natural killer cells induced by mono- and divalent cations. Journal of Structural Biology. 145: 263-71. PMID 14960377 DOI: 10.1016/J.Jsb.2003.11.001 |
0.337 |
|
2003 |
Johnson LA, Vaidya SV, Goldfarb RH, Mathew PA. 2B4(CD244)-mediated activation of NK cells reduces metastases of B16F10 melanoma in mice. Anticancer Research. 23: 3651-5. PMID 14666660 |
0.324 |
|
2003 |
Albertsson PA, Basse PH, Hokland M, Goldfarb RH, Nagelkerke JF, Nannmark U, Kuppen PJ. NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends in Immunology. 24: 603-9. PMID 14596885 DOI: 10.1016/J.It.2003.09.007 |
0.504 |
|
2003 |
Yang Q, Hokland ME, Bryant JL, Zhang Y, Nannmark U, Watkins SC, Goldfarb RH, Herberman RB, Basse PH. Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases. International Journal of Cancer. Journal International Du Cancer. 105: 512-9. PMID 12712443 DOI: 10.1002/Ijc.11119 |
0.439 |
|
2003 |
Gellert GC, Kitson RP, Goldfarb RH. Urokinase-type plasminogen activator receptor crosslinking in an NK cell line increases integrin surface expression by the MAP kinase/ERK 1/2 signaling pathway. Journal of Cellular Biochemistry. 89: 279-88. PMID 12704791 DOI: 10.1002/Jcb.10512 |
0.715 |
|
2003 |
Lu M, Kitson RP, Xue Y, Goldfarb RH. Activation of multiple caspases and modification of cell surface fas (CD95) in proteasome inhibitor-induced apoptosis of rat natural killer cells. Journal of Cellular Biochemistry. 88: 482-92. PMID 12532325 DOI: 10.1002/Jcb.10296 |
0.45 |
|
2002 |
Datta A, Kitson RP, Xue Y, al-Atrash G, Mazar AP, Jones TR, Goldfarb RH. Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases. In Vivo (Athens, Greece). 16: 451-7. PMID 12494889 |
0.595 |
|
2002 |
Chen WS, Kitson RP, Goldfarb RH. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1). In Vivo (Athens, Greece). 16: 439-45. PMID 12494887 |
0.344 |
|
2002 |
Al-Atrash G, Shetty S, Idell S, Xue Y, Kitson RP, Halady PK, Goldfarb RH. IL-2-mediated upregulation of uPA and uPAR in natural killer cells. Biochemical and Biophysical Research Communications. 292: 184-9. PMID 11890690 DOI: 10.1006/Bbrc.2002.6627 |
0.653 |
|
2001 |
Al-Atrash G, Kitson RP, Xue Y, Mazar AP, Kim MH, Goldfarb RH. uPA and uPAR contribute to NK cell invasion through the extracellular matrix. Anticancer Research. 21: 1697-704. PMID 11497249 |
0.719 |
|
2001 |
Kuppen PJ, van der Eb MM, Jonges LE, Hagenaars M, Hokland ME, Nannmark U, Goldfarb RH, Basse PH, Fleuren GJ, Hoeben RC, van de Velde CJ. Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer. Histochemistry and Cell Biology. 115: 67-72. PMID 11219610 DOI: 10.1007/S004180000224 |
0.425 |
|
2000 |
Nannmark U, Hokland ME, Agger R, Christiansen M, Kjaergaard J, Goldfarb RH, Bagge U, Unger M, Johansson BR, Albertsson PA, Basse PH. Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells. In Vivo (Athens, Greece). 14: 651-8. PMID 11125549 |
0.389 |
|
2000 |
Johnson LA, Goldfarb RH, Mathew PA. Regulation of IFN-gamma production following 2B4 activation in human NK cells. In Vivo (Athens, Greece). 14: 625-9. PMID 11125547 |
0.338 |
|
2000 |
al-Atrash G, Kitson RP, Xue Y, Goldfarb RH. Cooperation of urokinase plasminogen activator and matrix metalloproteinases in NK cell invasion. In Vivo (Athens, Greece). 14: 565-70. PMID 11125540 |
0.691 |
|
2000 |
Chuang SS, Kim MH, Johnson LA, Albertsson P, Kitson RP, Nannmark U, Goldfarb RH, Mathew PA. 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness. Immunology. 100: 378-83. PMID 10929061 DOI: 10.1046/J.1365-2567.2000.00031.X |
0.491 |
|
2000 |
Guo Y, Higazi AA, Arakelian A, Sachais BS, Cines D, Goldfarb RH, Jones TR, Kwaan H, Mazar AP, Rabbani SA. A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 14: 1400-10. PMID 10877833 DOI: 10.1096/Fasebj.14.10.1400 |
0.412 |
|
2000 |
Kim MH, Kitson RP, Albertsson P, Nannmark U, Basse PH, Kuppen PJ, Hokland ME, Goldfarb RH. Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. Journal of Immunology (Baltimore, Md. : 1950). 164: 5883-9. PMID 10820269 DOI: 10.4049/Jimmunol.164.11.5883 |
0.41 |
|
2000 |
Albertsson P, Kim MH, Jonges LE, Kitson RP, Kuppen PJ, Johansson BR, Nannmark U, Goldfarb RH. Matrix metalloproteinases of human NK cells. In Vivo (Athens, Greece). 14: 269-76. PMID 10757086 |
0.386 |
|
2000 |
Kitson RP, Lu M, Siman R, Goldfarb RH. Proteasome inhibitor and lymphocyte function: partial inhibition of cell-mediated cytotoxicity and implication that the lymphocyte proteasome may contain multiple chymotryptic domains. In Vivo (Athens, Greece). 14: 265-8. PMID 10757085 |
0.436 |
|
2000 |
Goldfarb RH, Koelemij R, Muirhead KA, Ohlsson-Wilhelm BM, Gray BD, Kuppen PJ, Basse PH, al-Atrash G, Kitson RP. A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin. In Vivo (Athens, Greece). 14: 101-4. PMID 10757065 |
0.677 |
|
1999 |
Mazar AP, Henkin J, Goldfarb RH. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis. 3: 15-32. PMID 14517441 DOI: 10.1023/A:1009095825561 |
0.467 |
|
1999 |
Goldfarb RH, Kitson RP, Brunson KW, Yoshino K, Hirota N, Kirii Y, Kotera Y, Inoue Y, Ohashi M. Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles. Anticancer Research. 19: 1663-7. PMID 10470098 |
0.389 |
|
1998 |
An B, Goldfarb RH, Siman R, Dou QP. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death and Differentiation. 5: 1062-75. PMID 9894613 DOI: 10.1038/Sj.Cdd.4400436 |
0.344 |
|
1998 |
Kitson RP, Ohashi M, Brunson KW, Goldfarb RH. Flavone acetic acid enhances accumulation of IL-2 activated NK cells within established metastases. In Vivo (Athens, Greece). 12: 593-7. PMID 9891222 |
0.437 |
|
1998 |
Goldfarb RH, Albertsson P, Nannmark U, Kitson RP. Cytolytic activities of IL-2 activated NK cells from MMTV/v-Ha-ras transgenic oncomice during tumor progression. In Vivo (Athens, Greece). 12: 589-92. PMID 9891221 |
0.396 |
|
1998 |
Goldfarb RH, Ohashi M, Brunson KW, Kirii Y, Kotera Y, Basse PH, Kitson RP. Augmentation of IL-2 activated natural killer cell adoptive immunotherapy with cyclophosphamide. Anticancer Research. 18: 1441-6. PMID 9673353 |
0.373 |
|
1998 |
Kitson RP, Appasamy PM, Nannmark U, Albertsson P, Gabauer MK, Goldfarb RH. Matrix metalloproteinases produced by rat IL-2-activated NK cells. Journal of Immunology (Baltimore, Md. : 1950). 160: 4248-53. PMID 9574526 |
0.411 |
|
1997 |
Ribeiro U, Basse PH, Rosenstein M, Safatle-Ribeiro AV, Alhallak S, Goldfarb RH, Posner MC. Retention of adoptively transferred interleukin-2-activated natural killer cells in tumor tissue. Anticancer Research. 17: 1115-23. PMID 9137458 |
0.369 |
|
1996 |
Nannmark U, Kitson RP, Johansson BR, Rivett AJ, Goldfarb RH. Immunocytochemical localization of multicatalytic protease complex (proteasome) during generation of murine IL-2-activated natural killer (A-NK) cells. European Journal of Cell Biology. 71: 402-8. PMID 8980912 |
0.443 |
|
1996 |
Saxena RK, Saxena QB, Whiteside TL, Goldfarb RH, Herberman RB. Partial purification and characterization of a novel human factor that augments the expression of class I MHC antigens on tumour cells Journal of Biosciences. 21: 13-25. DOI: 10.1007/Bf02716809 |
0.369 |
|
1996 |
Saxena QB, Saxena RK, Goldfarb RH, Herberman RB, Whiteside TL. Identification and partial purification of a human natural killer cell proliferation-inducing factor Journal of Biosciences. 21: 455-469. DOI: 10.1007/Bf02703210 |
0.42 |
|
1995 |
Kitson RP, Miller CA, Goldfarb RH. Non-granular proteolytic enzymes of rat interleukin-2-activated natural killer cells. III. Enhancement of A-NKP 1, 2, and 3 proteolytic activities (cleaving after Arg, Phe and Pro) in response to interleukin-2. Natural Immunity. 14: 286-94. PMID 8933822 |
0.407 |
|
1995 |
Welch WC, Morrison RS, Gross JL, Gollin SM, Kitson RB, Goldfarb RH, Giuliano KA, Bradley MK, Kornblith PL. Morphologic, immunologic, biochemical, and cytogenetic characteristics of the human glioblastoma-derived cell line, SNB-19. In Vitro Cellular & Developmental Biology. Animal. 31: 610-6. PMID 8528516 DOI: 10.1007/Bf02634314 |
0.364 |
|
1995 |
Nannmark U, Johansson BR, Bryant JL, Unger ML, Hokland ME, Goldfarb RH, Basse PH. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Cancer Research. 55: 4627-32. PMID 7553640 |
0.348 |
|
1994 |
Goldfarb RH, Whiteside TL, Basse PH, Lin WC, Vujanovic N, Herberman RB. Natural killer cells and gene therapy: Potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases Natural Immunity. 13: 131-140. PMID 8173234 |
0.347 |
|
1994 |
Kuppen PJK, Basse PH, Goldfarb RH, Van de Velde CJH, Fleuren GJ, Eggermont AMM. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats International Journal of Cancer. 56: 574-579. PMID 8112894 DOI: 10.1002/Ijc.2910560418 |
0.482 |
|
1994 |
Wasserman K, Kitson RP, Rivett AJ, Sweeney ST, Gabauer MK, Herberman RB, Watkins SC, Goldfarb RH. Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. II. Purification and identification of rat A-NKP 1 and A-NKP 2 as constituents of the multicatalytic proteinase (proteasome) complex. Journal of Cellular Biochemistry. 55: 133-45. PMID 8083294 DOI: 10.1002/Jcb.240550115 |
0.43 |
|
1994 |
Brunson KW, Ohashi M, Miller CA, Kitson RP, Basse PH, Goldfarb RH. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: Binding to microvascular endothelial cells and BRM enhancement of cytolytic activity In Vivo. 8: 71-75. PMID 8054514 |
0.407 |
|
1994 |
Wasserman K, Kitson RP, Gabauer MK, Miller CA, Herberman RB, Goldfarb RH. Zymographic analysis of extracellular, released and cell-associated proteases of rat interleukin 2-activated natural killer (A-NK) cells. In Vivo (Athens, Greece). 8: 33-41. PMID 8054509 |
0.406 |
|
1994 |
Kitson RP, Wasserman K, Goldfarb RH. Identification and enrichment of proteolytic enzymes of IL-2 activated rat natural killer (A-NK) cells: potential physiological roles in NK cell function. Immunology Series. 61: 83-92. PMID 8011759 |
0.365 |
|
1994 |
Whiteside TL, Goldfarb RH. Antitumor effector cells: extravasation and control of metastasis Immunology Series. 61: 159-173. PMID 8011740 |
0.375 |
|
1993 |
Goldfarb RH, Kornblith PL. Preface: Tumor invasion and brain cancer Journal of Neuro-Oncology. 18. DOI: 10.1007/Bf01050414 |
0.382 |
|
1992 |
Basse P, Herberman RB, Hokland M, Goldfarb RH. Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels Cancer Immunology Immunotherapy. 34: 221-227. PMID 1537054 DOI: 10.1007/Bf01741789 |
0.395 |
|
1992 |
Goldfarb RH, Wasserman K, Herberman RB, Kitson RP. Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role. Journal of Immunology (Baltimore, Md. : 1950). 149: 2061-8. PMID 1517570 |
0.404 |
|
1992 |
Basse PH, Herberman RB, Hokland ME, Goldfarb RH. Tissue distribution of adoptively transferred adherent LAK cells: Role of the route of administration Natural Immunity. 11: 193-202. PMID 1421955 |
0.315 |
|
1992 |
Goldfarb RH, Brunson KW. Therapeutic agents for treatment of established metastases and inhibitors of metastatic spread: Preclinical and clinical progress Current Opinion in Oncology. 4: 1130-1141. PMID 1281001 DOI: 10.1097/00001622-199212000-00019 |
0.316 |
|
1992 |
Saxena QB, Saxena RK, Goldfarb RH, Whiteside TL, Herberman RB. EVIDENCE FOR THE PRESENCE OF TWO NOVEL CYTOKINES IN SUPERNATANTS OF CONCANAVA- LIN A-ACTIVATED HUMAN PERIPHERAL BLOOD LYMPHOCYTES Journal of Immunotherapy. 11: 143. DOI: 10.1097/00002371-199202000-00056 |
0.31 |
|
1991 |
Basse PH, Nannmark U, Johansson BR, Herberman RB, Goldfarb RH. Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells Journal of the National Cancer Institute. 83: 944-950. PMID 2067037 DOI: 10.1093/Jnci/83.13.944 |
0.504 |
|
1991 |
Basse P, Herberman RB, Nannmark U, Johansson BR, Hokland M, Wasserman K, Goldfarb RH. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. The Journal of Experimental Medicine. 174: 479-88. PMID 1856630 DOI: 10.1084/Jem.174.2.479 |
0.474 |
|
1989 |
Sasaki A, Jain RK, Maehazachi AA, Goldfarb RH, Herberman RB. Low Deformability of Lymphokine-activated Killer Cells as a Possible Determinant of in Vivo Distribution Cancer Research. 49: 3742-3746. PMID 2500233 |
0.397 |
|
1988 |
Al Maghazachi A, Goldfarb RH, Herberman RB. Influence of T cells on the expression of lymphokine-activated killer cell activity and in vivo tissue distribution Journal of Immunology. 141: 4039-4046. PMID 2846699 |
0.363 |
|
1986 |
Goldfarb RH. Role of neutral serine proteases in tumor cell lysis by natural killer cells (large granular lymphocytes) and activated macrophages Seminars in Thrombosis and Hemostasis. 12: 308-309. PMID 3538423 |
0.417 |
|
1984 |
Goldfarb RH, Timonen T, Herberman RB. Production of plasminogen activator by human natural killer cells. Large granular lymphocytes Journal of Experimental Medicine. 159: 935-951. PMID 6199454 DOI: 10.1084/Jem.159.3.935 |
0.52 |
|
1983 |
Jones CM, Goldfarb RH, Holden HT. Macrophage cell lines behave as activated macrophages in the production and regulation of plasminogen activator Cancer Investigation. 1: 207-213. PMID 6686788 DOI: 10.3109/07357908309041360 |
0.313 |
|
1983 |
Goldfarb RH, Berendt MJ. Chapter 27. Natural Killer Cells: Role in Cell-Mediated Immunity Annual Reports in Medicinal Chemistry. 18: 265-273. DOI: 10.1016/S0065-7743(08)60782-4 |
0.317 |
|
1982 |
Goldfarb RH, Timonen T, Herberman RB. Mechanism of tumor cell lysis by natural killer cells Advances in Experimental Medicine and Biology. 146: 403-421. PMID 6285682 |
0.378 |
|
1982 |
Goldfarb RH, Timonen TT, Herberman RB. The Role Of Neutral Serine Proteases In The Mechanism Of Tumor Cell Lysis By Human Natural Killer Cells Nk Cells and Other Natural Effector Cells. 931-938. DOI: 10.1016/B978-0-12-341360-4.50139-6 |
0.522 |
|
1982 |
Goldfarb RH, Herberman RB. Inhibition Of Natural Killer Cell Cytotoxic Reactivity By Tumor Promoters And Cholera Toxin Nk Cells and Other Natural Effector Cells. 595-600. DOI: 10.1016/B978-0-12-341360-4.50094-9 |
0.512 |
|
1982 |
Goldfarb RH, Herberman RB. Augmentation Of Natural Killer Activity By Retinoic Acid Nk Cells and Other Natural Effector Cells. 427-430. DOI: 10.1016/B978-0-12-341360-4.50070-6 |
0.455 |
|
1981 |
Hoffman T, Hirata F, Bougnoux P, Fraser BA, Goldfarb RH, Herberman RB, Axelrod J. Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells. Proceedings of the National Academy of Sciences of the United States of America. 78: 3839-43. PMID 6943585 DOI: 10.1073/pnas.78.6.3839 |
0.37 |
|
1981 |
Goldfarb RH, Herberman RB. Natural killer cell reactivity: Regulatory interactions among phorbol ester, interferon, cholera toxin, and retinoic acid Journal of Immunology. 126: 2129-2135. PMID 6164721 |
0.42 |
|
1980 |
Goldfarb RH, Quigley JP. Purification of plasminogen activator from Rous sarcoma virus transformed chick embryo fibroblasts treated with the tumor promoter phorbol 12-myristate 13-acetate Biochemistry. 19: 5463-5471. PMID 6257279 DOI: 10.1021/Bi00565A001 |
0.512 |
|
1980 |
Quigley JP, Goldfarb RH, Scheiner C, O'Donnell-Tormey J, Yeo TK. Plasminogen activator and the membrane of transformed cells. Progress in Clinical and Biological Research. 41: 773-96. PMID 6256777 |
0.572 |
|
1978 |
Goldfarb RH, Quigley JP. Synergistic Effect of Tumor Virus Transformation and Tumor Promoter Treatment on the Production of Plasminogen Activator by Chick Embryo Fibroblasts Cancer Research. 38: 4601-4609. PMID 214228 |
0.522 |
|
Show low-probability matches. |